Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry
暂无分享,去创建一个
G. Lip | M. Zubaid | A. Alsheikh-Ali | N. Asaad | W. Rashed | M. Proietti | J. Gumprecht | Yan‐Guang Li | M. Domek | Marco Proietti | Magdalena Domek
[1] P. Friedman,et al. Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.
[2] G. Lip,et al. Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management , 2019, Journal of Human Hypertension.
[3] G. Lip,et al. A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention , 2019, Expert opinion on drug safety.
[4] T. Chao,et al. Should we judge stroke risk by static or dynamic risk scores? A focus on the dynamic nature of stroke and bleeding risks in patients with atrial fibrillation. , 2019, Journal of cardiovascular pharmacology.
[5] G. Lip,et al. Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study , 2019, Thrombosis and Haemostasis.
[6] A. Farcomeni,et al. ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study. , 2019, The American journal of medicine.
[7] F. Violi,et al. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. , 2019, Mayo Clinic proceedings.
[8] G. Lip,et al. Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. , 2018, American Journal of Medicine.
[9] G. Boriani,et al. Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. , 2018, European journal of internal medicine.
[10] S. Connolly,et al. Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]). , 2017, The American journal of cardiology.
[11] G. Lip. The ABC pathway: an integrated approach to improve AF management , 2017, Nature Reviews Cardiology.
[12] G. Lip,et al. Stroke prevention in atrial fibrillation: Past, present and future , 2017, Thrombosis and Haemostasis.
[13] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[14] Sally Hopewell,et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis , 2016, British Medical Journal.
[15] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.
[16] M. Rienstra,et al. Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study). , 2016, American heart journal.
[17] M. Houmsse,et al. The current approach of atrial fibrillation management , 2016, Avicenna Journal of Medicine.
[18] H. Crijns,et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. , 2012, European heart journal.
[19] M. Zubaid,et al. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): Design and Baseline Characteristics of Patients With Atrial Fibrillation in the Arab Middle East , 2011, Circulation. Cardiovascular quality and outcomes.
[20] S. Lévy,et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. , 2007, American heart journal.
[21] S. Connolly,et al. Title: Predictors of Mortality in Patients with Atrial Fibrillation (From the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events , 2017 .